{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:22:53Z","timestamp":1783441373553,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.surg.2015.06.057","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T11:02:15Z","timestamp":1444042935000},"page":"211-217","source":"Crossref","is-referenced-by-count":17,"title":["FGF23, metabolic risk factors, and\u00a0blood pressure in patients with\u00a0primary hyperparathyroidism undergoing parathyroid adenomectomy"],"prefix":"10.1016","volume":"159","author":[{"given":"Inga-Lena","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Norenstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Granath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Pernow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias E.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2015.06.057_bib1","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.surg.2015.06.057_bib2","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.surg.2015.06.057_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.surg.2015.06.057_bib4","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.surg.2015.06.057_bib6","first-page":"N68","article-title":"Clinical presentation of primary hyperparathyroidism in Europe\u2014nationwide cohort analysis on mortality from nonmalignant causes","volume":"17","author":"Nilsson","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.surg.2015.06.057_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2015.06.057_bib8","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2015.06.057_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib10","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.surg.2015.06.057_bib11","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.surg.2015.06.057_bib12","doi-asserted-by":"crossref","first-page":"e60658","DOI":"10.1371\/journal.pone.0060658","article-title":"Arterial klotho expression and FGF23 effects on vascular calcification and function","volume":"8","author":"Lindberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2015.06.057_bib13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib14","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","article-title":"Primary hyperparathyroidism and heart disease\u2014a review","volume":"25","author":"Andersson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.surg.2015.06.057_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1067\/msy.2001.118368","article-title":"Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia","volume":"130","author":"Nilsson","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2015.06.057_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-13-0547","article-title":"Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study","volume":"169","author":"Norenstedt","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2015.06.057_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.surg.2015.06.057_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib19","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2008-0564","article-title":"Type I membrane Klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism","volume":"93","author":"Bj\u00f6rklund","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2015.06.057_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.surg.2015.06.057_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2015.06.057_bib23","doi-asserted-by":"crossref","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","article-title":"Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion","volume":"9","author":"Olauson","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.surg.2015.06.057_bib24","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","article-title":"FGF-23 is elevated by chronic hyperphosphatemia","volume":"89","author":"Gupta","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2015.06.057_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00126097-200112000-00016","article-title":"Task Force II: blood pressure measurement and cardiovascular outcome","volume":"6","author":"Staessen","year":"2001","journal-title":"Blood Press Monit"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015007060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606015007060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T22:51:34Z","timestamp":1617663094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606015007060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0039606015007060"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2015.06.057","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}